RxNorm 2718406 NDC Crossover
afluria 2025-2026 vaccine 0.5 ML Injectable Suspension
Related NDC Codes to RxNorm Concept 2718406
The following NDC codes crossover to the RxNorm Concept 2718406. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
|---|---|---|---|---|---|---|---|
| 33332-024 | Afluria | Seqirus Pty Ltd. | |||||
| 33332-025 | Afluria | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (propiolactone Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (propiolactone Inactivated), Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (propiolactone Inactivated) | Injection, Suspension | Intramuscular | Seqirus Pty Ltd. | ACTIVE | |
| 33332-124 | Afluria | Seqirus Pty Ltd. | |||||
| 33332-125 | Afluria | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (propiolactone Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (propiolactone Inactivated), Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (propiolactone Inactivated) | Injection, Suspension | Intramuscular | Seqirus Pty Ltd. | ACTIVE |
